Pharma article - June 10, 2026
Nose to nose with the future of drug delivery
Once limited to decongestants, nasal drug delivery is emerging as one of medicine’s most promising frontiers, offering faster uptake, stronger immunity, and the potential to block transmission before disease takes hold.
Pharma article - June 8, 2026
Ipsen moves Nordic headquarters to Hagastaden
Ipsen is relocating its Nordic headquarters from Kista to Hagastaden, one of Stockholm’s most dynamic life science hubs.
Pharma article - May 18, 2026
AtrimusRx joins EU RoboPharma project
The company is part of a new EU‑funded consortium developing an AI‑ and robotics‑driven manufacturing platform to secure access to critical medicines during shortages and supply chain disruptions.
Biotech article - April 20, 2026
In focus: Nasal drug delivery for quicker uptake
Nasal drug delivery is a dynamic area in pharmaceutical innovation. What was once a route for decongestants and allergy sprays is now being explored for everything from emergency treatments to vaccines – and even shows potential for future central nervous system therapies.
Pharma article - April 11, 2026
Alfa Laval sharpens focus on serving pharmaceutical production
Alfa Laval has implemented a transformation of its organization to establish the Food & Pharma Division.
Collaboration - March 17, 2026
Taking Nordic research on personalized pharmaceuticals to the next level
A large-scale Nordic collaboration has developed the research on personalized pharmaceuticals and led to researcher training and mobility, new patient-oriented products, new technologies and startups.